Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × palbociclib × Clear all

NCT02905318 2026-03-09

Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT02059213 2020-09-16

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

Phase 2 Completed

72 enrolled 15 charts

Prostatic Neoplasms